Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
31 Cards in this Set
- Front
- Back
What is PCA & how is it typically administered
|
Patient-Controlled Analgesia: Pt can deliver small doses of pain meds relatively frequently for optimal pain control
Via IV or into Spinal Canal |
|
Give the Pros and Cons of PCA
|
Pro: Pain control is achievable with less drug often times resulting in less side effects
Con: Potential user error (not clicking button); operator error (nurse types dosage in wrong); mechanical problems with pump |
|
Give the main benefit of PCA use
|
Tighter control of concentration of drug in pt's bloodstream--results in less fluctuations with PCA vs oral or bolus administration b/c of more smaller dosages ---results in decreased sedation side effects
|
|
What is the loading dose
|
Initial large dose that brings concentration up to analgesic range
|
|
Demand dose
|
Amount administered when the patient clicks the button
|
|
Lockout Interval?
|
Minimum amount of time alotted b/t doses--won't deliver dose if button pushed earlier than lockout interval
|
|
What is the background infusion rate?
|
Occasionally their is a small amt of drug being given continuously without button push--(during sleep)
Not used as much b/c its more difficult to avoid side effects b/c pt cant stop pushing button if dose becomes to large & side effects ensue |
|
What are total demands? Successful demands?
|
Total demands are the # of times pt has tried to receive medicine
Successful demands are the # of times the pt pushes the button & receives demand dose of drug |
|
What drugs are used with PCA
|
1. Opiod--pain relief
2. Opiod/Non-opiod combination--Tylenol or NSAID 3. Opiod/Anesthetic 4. Anesthetic |
|
What are options for PCA delivery
|
1. IV
2. Epidural 3. Transdermal--patch --Cancer/chronic pain pts may have PCA for long term use |
|
Define RA
|
Chronic, systemic disease primarily characterized by synovitis & articular tissue destruction
|
|
S&S of RA
|
Pain, Swelling, inflammation, stiffness
|
|
Give typical joints affected with RA
|
Smaller joints--hands, wrists, & feet
|
|
Describe RA's typical disease course
|
Progressive disease--pts will be in periods of remission
Their are juvenile and adult forms but they are treated similar |
|
Describe the etiology and treatment goals with RA
|
Etiology-- somewhat unknown--an autoimmune response occurs, with the end result of synovitis and articular destruction
Txt Goals: 1. Dec inflammation 2. Stop disease progression |
|
What are options for decreasing inflammation associated with RA
|
1. NSAIDs--very common txt
-Have analgesic and anti-inflammatory effects with less side effects than glucocorticoids -Acetaminophen--not used bc no anti-inflammatory effects |
|
What are DMARDs
|
Disease-modifying antirheumatic drugs
-Heterogeneous group that seem to slow or stop the RA disease process -Most modify the immune response --for many unknown MOA -Slow acting: often take 6 weeks to 6 months to see an effect - Somewhat controversial: some have serious side effects--trying to combine different DMARDs together to reduce side effects Essentially they attack the autoimmunity |
|
Give Examples of Types of DMARDs
|
1. Anticancer drugs (Methotrexate or Rheumatrex) --oftin 1st choice & key drug in combination therapy txt
2. Immune Suppressants (Azathioprine or Imuran)--for severe & active RA---not used if pt is in remission--potentially has flu-like symptoms and increases fatigue 3. Anti-Inflammatory (Gold Compounds) : used if others are ineffective 4. Anti-Inflammatory via TNF-a inhibition (Infliximab or Remicade) --Newer There is a broad variety of drugs used and they are mostly used in combination |
|
Why is TNF-a inhibition potentially helpful in treatment of RA
|
TNF-a is involved in the inflammatory response in RA
It binds with tissue to cause inflammation but Infliximab binds to TNF-a & modifies its shape so that it cannot bind to the joint tissue--the drug may also mimic TNF-a shape & compete for tissue receptors |
|
What could be potential problems with RA pts exercising
|
Increased fatigue and immune response
|
|
What is another worry for RA pts
|
Liver and kidney toxicity d/t increased drug intake
|
|
What are 2 options for non-pharmaceutical treatment of OA
|
PT & joint replacement
|
|
What types of drugs are used to treat RA
|
1. NSAIDs
2. Acetominophen (depending if jts are highly inflamed) 3. Disease -modifying OA drugs--Viscosupplementation and supplementation of precursors to joint tissue constituents |
|
Describe Viscosupplementation in the Txt of OA
|
-Administered with injection of hyaluron into the joint--may restore lubricating properties of the joint
-Relatively transient response but can last up to 6 mo -Can delay need for sx & usually tolerated well Adverse effect: local pain and inflammation can occur |
|
Describe precursor to joint constituents supplementation
|
Glucosamine: one of the substrates for cartilage production
Chondroitin Sulfate: key component of synovial fluid along with glucosamine PROs: may decrease pain/inflammation CONs: may cause GI problems These are usually well tolerated so it doesn't hurt to try--usually takes a # of weeks to start working |
|
Describe the immune basis for RA
|
Some type of autoimmune response occurs in genetically susceptible pts after some sort of precipitating factor such as a virus or infection
The precipitating factor seems to initiate the formation of antibodies that are later recognized at antigens--results in destruction of art cartilage and bone |
|
Give criteria for classification of RA
|
1. Morning stiffness
2. Arthritis of 3 or more joint areas 3. Arthritis of hand joints 4. Symmertric Arthritis 5. Serum Rhematoid factor |
|
What are the 2 goals of RA drug txt
|
1. Decrease joint inflammation
2. Arrest the progression of this disease |
|
What are 3 categories of drugs used for RA
|
1. NSAIDs
2. Glucocorticoids 3. Disease Modifying Antirheumatic drugs (DMARDs) |
|
Define DMARDs and give their indication
|
DMARDs are medications that retard or halt the progression of RA
Early and aggressive use of DMARDs can slow the progression of RA before there is extensive damage to affected joints |
|
How do DMARDs work?
|
Attempt to induce remission by inhibiting certain aspects of the immune resonse thought to be underlying RA
Inhibit the fxn of monocytes and T & B lymphocytes that are responsible for perpetuating joint inflammation and destruction |